Prescription drug · UNAPPROVED DRUG OTHER
NP Thyroid 15 NDC 63629-8265
levothyroxine, liothyronine · Levothyroxine 9.5 ug/1; Liothyronine 2.25 ug/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63629-8265-1 | 63629826501 | 30 TABLET in 1 BOTTLE (63629-8265-1)Marketed from Apr 8, 2025 | |
| 63629-8265-2 | 63629826502 | 90 TABLET in 1 BOTTLE (63629-8265-2)Marketed from Apr 8, 2025 | |
| 63629-8265-3 | 63629826503 | 60 TABLET in 1 BOTTLE (63629-8265-3)Marketed from Apr 8, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- NP Thyroid 15
- Generic name (nonproprietary)
- levothyroxine, liothyronine
- Active ingredients
- Levothyroxine — 9.5 ug/1Liothyronine — 2.25 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Thyroxine (Chemical structure)Triiodothyronine (Chemical structure)
- Identifiers
- Product ID 63629-8265_3361dadf-685c-3c9c-e063-6394a90aaefaSPL ID 3361dadf-685c-3c9c-e063-6394a90aaefaSPL set ID 647df9e7-5234-4de6-bce5-bb2cf0c5c7e6UNII Q51BO43MG4, 06LU7C9H1V
- Pharmacologic class
- l-Thyroxine; l-Triiodothyronine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463629826501followed by a unit qualifier and the quantityPackage 63629-8265-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE NP Thyroid ® tablets (thyroid tablets, USP) are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WA…
Excerpt only. Read the full label for complete information.